5th Joint Meeting of ABCD & The Renal Association - Programme

5th Joint Meeting

24th February, 17.30 to 19:30

Time Title
17:30 Open and welcome
Professor Stephen Bain, Swansea University
17:35 Improving collaborative care for people with diabetes and kidney disease - delivering care across the system Chaired by Dr Sagen Zac-Varghese
Northern Ireland Experience, Dr Damien Fogarty
South East London Experience - The MD Community diabetes renal clinic, Dr Alice Rickford & Anna Hodgkinson
East Herts Experience - community work, Dr Peter Winocour
Dr. Damian Fogarty, Belfast
Dr. Alice Rickford, Akerman Health Centre
Miss Anna Hodgkinson, NHS South East London CCG
Dr. Peter Winocour, East and North Hertfordshire NHS Trust
Dr. Sagen Zac-Varghese, East and North Herts NHS Trust
18:35 New technologies and the haemodialysis unit Chaired by Dr Mona Wahba
Dr. Sufyan Hussain, Guy’s and St Thomas Hospital
Dr. Mona Wahba, Epsom and St Helier University Hospitals NHS Trust
19:00 A person-centred approach to help improving care for people with diabetes and kidney disease Chaired by Dr Mona Wahba
Dr. Charles Fox, Northampton General Hospital
Dr. Anne Kilvert, Northamptonshire Community Diabetes Multidisciplinary Team
Dr. Mona Wahba, Epsom and St Helier University Hospitals NHS Trust


25th February, 17.30 to 19:30

Time Title
17:30 Welcome
Professor Indranil Dasgupta, Heartlands Hospital
17:35 Symposium on expanding the use of SGLT2i Chaired by Dr Rosa Montero
Cardiology & SGLT2i, Prof Mark Petrie
Renal & SGLT2i, Prof David Wheeler
Safe prescribing, Dr Ana Pokrajac
Dr. Mark Petrie, University of Glasgow / Glasgow Royal Infirmary
Professor David Wheeler, University College London
Dr. Ana Pokrajac, West Herts Hospital Trust
Dr. Rosa Montero, Kings College London
18:15 Abstract presentations Chaired by Prof Patrick Mark
Presentations of the top 3 abstracts from those submitted. Q&A will follow after the final presentation.
1. Afro-Caribbean ethnicity and glycaemic variability are associated with non-linear estimated glomerular filtration rate decline in type 2 diabetes with diabetic nephropathy, Stanimir Stoilov, Guy's and St Thomas' NHS Foundation Trust, London
2. Is it time to use continuous glucose monitoring (CGM) in dialysis? Results of an observational study using CGM in patients with Type 2 diabetes and chronic kidney disease (CKD) stage 3-5, or on haemodialysis, Dr Hsiu Lye Yap, Imperial College London
3. The impact of empagliflozin on eGFR and albuminuria: results from the ABCD nationwide empagliflozin audit, Dr Thomas Crabtree, University Hospitals of Derby and Burton NHS Trust
Professor Patrick Mark, Glasgow
18:45 Guidelines for the care of people with diabetes & kidney disease, what's new? Chaired by Dr Parijat De
Post transplant, Dr Adnan Sharif
Lipid, Dr Sagen Zac-Varghese
Hypertension, Prof Debasish Banerjee
Glycaemia, Prof Steve Bain
Dr. Adnan Sharif, Queen Elizabeth Hospital Birmingham
Dr. Sagen Zac-Varghese, East and North Herts NHS Trust
Professor Debasish Banerjee, St Georges Hospital
Professor Stephen Bain, Swansea University
Dr. Parijat De, City Hospital

Thank you to our Gold Corporate Supporters for 2021

2021 ABCD Sponsors

5th Joint Meeting Information